Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Esophageal Neoplasms × HMPL-013 × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 18 Stomach Neoplasms 3 Colonic Neoplasms 3 Sarcoma 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Metastatic Gastroesophageal Junction Adenocarcinoma 1 Metastatic Colorectal Adenocarcinoma 1 MSS Metastatic Colorectal Cancer 1 Gastric/Gastroesophageal Junction Adenocarcinoma 1 Gastric Cancer Adenocarcinoma Metastatic 1 Fruquintinib 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Cancer Metastatic 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Advanced/Metastatic Solid Tumors 1 Advanced Solid Tumors 1

Interventions

Paclitaxel 15 pembrolizumab 14 Radiotherapy 11 Cisplatin 11 Esophagectomy 9 Drug Therapy 9 Carboplatin 9 Radiation 8 Nivolumab 7 Immunotherapy 7 Fluorouracil 7 Blood Specimen Collection 7 Chemoradiotherapy 6 Capecitabine 6 Surgical Procedures, Operative 5 Oxaliplatin 5 Immune Checkpoint Inhibitors 5 nimotuzumab 4 Trastuzumab 4 130-nm albumin-bound paclitaxel 4 trastuzumab deruxtecan 3 tislelizumab 3 patritumab deruxtecan 3 camrelizumab 3 Surveys and Questionnaires 3 Specimen Handling 3 Ramucirumab 3 Magnetic Resonance Spectroscopy 3 Leucovorin 3 Endoscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06646588 2024-10-17

SJZ-RMEEC01

Hebei Medical University Fourth Hospital

Phase 2 Recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡